were recommended a treatment change in one national, cross-specialty second-opinion program
- Study population
- 6,791 completed second opinions
- Setting
- Multiple medical specialties
- Study period
- 2011–2012 · published 2015


OUTCOMES & EVIDENCE
Published second-opinion research can show what happened in a defined population. It cannot forecast your cardiac result—or stand in for verified WHITEGLOVEMD follow-up data.
Label the source. State the denominator. Show the limitation.
THREE DIFFERENT QUESTIONS
Trust depends on knowing which kind of statement you are reading. This page keeps the lines visible.
A finding from a defined study population. The study design, sample, specialty mix, and endpoint determine what the number can support.
What WHITEGLOVEMD is designed to deliver: two specialty perspectives, one co-signed report, transparent pricing, and a defined turnaround after the case is complete.
What happened after a WHITEGLOVEMD review. Those claims require verified follow-up, clear denominators, and explicit definitions. Published studies from another program are not a substitute.
PUBLISHED SECOND-OPINION EVIDENCE
The 37.4% figure comes from a national patient-initiated second-opinion program. It describes a recommended treatment change in that studied cohort; it does not measure a WHITEGLOVEMD population or predict an individual cardiac result.
Open the source publicationA recommended change to the treatment plan—not proof that the new recommendation was followed or produced a better clinical outcome.
6,791 patient-initiated second opinions across medical specialties, not a cardiac-surgery-only cohort.
Meyer and colleagues, published in The American Journal of Medicine in 2015.
The result cannot be relabeled as a WHITEGLOVEMD treatment-change rate, complication reduction, or cost saving.

WHAT A USEFUL REVIEW CAN PRODUCE
A second opinion should make the reasoning easier to inspect—whether it agrees with the original plan or raises a new question. These are possible review outputs, not promised outcomes.
The report makes the diagnosis, proposed procedure, timing, risk, and reasoning easier to understand before the patient moves forward.
The review may identify an alternative approach, a tradeoff, a guideline question, or a surgeon-and-center consideration to discuss with the treating team.
A study, image, measurement, or clinical detail may be needed before the decision can be evaluated with greater confidence.
SERVICE DESIGN · NOT OUTCOME CLAIMS
These numbers describe the service patients purchase. They do not claim that treatment will change or that a clinical outcome will improve.
Cardiac surgery and cardiology review the same complete case.
The reviewed consensus is organized in WHITEGLOVE Insights™.
The clock begins only after required records and imaging are confirmed complete.
The complete written Heart Team review is available without adding a live consultation.
WHITEGLOVE Insights™A cardiac surgeon and cardiologist review the same complete record, reconcile the decision, and co-sign one patient-facing report.
Explore the sample reportHOW COMPANY OUTCOMES SHOULD BE MEASURED
It needs a baseline, verified follow-up, a clear endpoint, and the people who could not be reached. Until then, the honest answer is that the result is not established.
Document the recommendation before the independent review so any later difference has a clear baseline.
A report can raise a question; only follow-up can establish what the patient and treating team ultimately chose.
Complications, readmissions, procedure changes, and recovery claims require reliable follow-up rather than inference from a report alone.
Any rate should state how many cases were eligible, how many were reached, what was missing, and the time period measured.
READ THE SOURCES
These links support the published finding and the clinical tools or guideline context referenced across the site.
FAQ
Still unsure what a study finding means for your decision? Request a complimentary orientation call before sending records.
Request a callNo. The study describes one national patient-initiated second-opinion program across medical specialties. It does not predict what will happen in an individual cardiac case. A review may confirm the current plan, raise a focused question, or identify missing information.
No. It is a published finding from Meyer and colleagues in The American Journal of Medicine. WHITEGLOVEMD does not present that percentage as its own treatment-change rate or as evidence of a clinical benefit caused by its service.
This page does not make those claims. Demonstrating a complication reduction, cost saving, or outcome advantage requires verified follow-up data, a defined comparison, and transparent denominators. A published second-opinion study cannot establish those results for WHITEGLOVEMD.
A cardiac surgeon and cardiologist independently review the complete case and co-sign one patient-facing WHITEGLOVE Insights™ report. The written review is delivered within 24 hours after the required records and imaging are confirmed complete. Pricing is shared during your complimentary discovery call.
Agreement can still be useful when the report makes the diagnosis, procedure, alternatives, risk, and reasoning easier to understand. The goal is not to manufacture disagreement; it is to make the decision more visible before the patient consents.
Every written review brings together two independent specialty perspectives: cardiac surgery and cardiology. Both reviewing physicians evaluate the case and sign the final report.
WHITEGLOVEMD can measure operational facts such as whether a complete case received both specialty reviews, whether the report was co-signed, and when the completed report was delivered. Clinical claims such as treatment changes, complications, readmissions, recovery, or cost savings require separate verified follow-up and transparent denominators.
The 24-hour review window begins only after the required medical records and imaging are received and confirmed complete. Record collection time is separate, and the records team can help identify and request missing material after authorization.
Yes. The report is designed to support a more focused conversation with the treating team. It is educational decision support and does not replace the clinicians responsible for diagnosis, prescriptions, emergency care, or treatment.
WHITEGLOVEMD is not an emergency service. Call 911 or seek immediate local emergency care for chest pain, severe shortness of breath, fainting, new weakness, or another possible medical emergency.
YOUR INCISION SHOULD BE YOUR DECISION™
Choose the independent written review or request a complimentary call to understand the process first.
